The World Health Organization states that one in every six deaths is attributable to cancer. This condition is characterized by an uncontrolled growth of cells in various parts of the human body, generally due to genetic mutations.
In spite of cancer having become a major cause of mortality, progress in creating new treatments for it has been limited. The primary methods used to treat cancer still include chemotherapy, radiation and removing the tumor surgically. Chemotherapeutic drugs may be a viable alternative to radiation or surgery when treating extensive cancer.
Most cancer treatments have severe side effects because they can harm healthy cells as well. Additionally, cancer therapy can be extremely costly and require a lot of time to develop. It is not uncommon to find new uses for already approved medications, like the use of a low dose of aspirin to prevent heart attacks.
It has been observed that certain medications that are already being used to treat cancer have anti-tumor properties. Clinical researchers believe that these discoveries could not only enhance cancer therapy but could also shorten the amount of time it takes to develop new cancer-fighting medicines. This appears to be true with the cancer-fighting dewormer used for dogs.
It is possible that Fenbendazole, a medicine used to treat parasites, could be beneficial in the treatment of cancer.
Fenbendazole is a very popular medication in veterinary medicine, and is used to fight off parasites and hookworms. Incredibly, this dewormer has been used to treat cancer, as Joe Tippens demonstrated when he utilized Panacur C as a therapy for his lung cancer. It is true – a dog dewormer is being used to treat cancer!
Ever since Joe Tippens shared his story of overcoming a deadly disease, the use of fenbendazole as a cancer treatment has become a highly contested issue. Multiple reports of fenbendazole yielding positive outcomes in cancer patients have circulated around cancer-related discussion boards and websites. While some are doubtful of the effectiveness of the drug in humans, others are replicating Joe’s regimen for their own cancer treatment.
Joe Tippens’ approach involves the combination of fenbendazole, tumeric, CBD oil, and vitamin E as a form of treatment. Vitamin E is not necessary for this plan, and tumeric and CBD are considered the two most important elements.
Is it safe for humans to eat dog deworming medication?
The question of whether an animal dewormer like fenbendazole is safe for humans has arisen due to its use primarily for dogs. Its toxicity is much lower than that of regular cancer medications, and several studies have been conducted to evaluate its safety. Findings suggest that the drug is safe for humans, as well as a variety of other animals, with virtually no adverse effects.
Research has suggested that a drug intended for treating dogs may potentially be useful in treating cancer. It has been observed that this drug has an effect on cancer cells in multiple ways, including inducing apoptosis (cell death). Thus, it is accurate to say that the original purpose of the drug has been re-purposed for use in treating human cancer.
What is the duration of the effectiveness of fenbendazole?
Fenbendazole is primarily known as a microtubule destabilizer. This medicine, which is used to treat cancer in humans, has micro-destabilizing properties that quickly halt the division of cancerous cells. Microtubules are highly specialized proteins that are involved in the many functions of our body’s cells, particularly those that reproduce quickly, like cancer cells.
Microtubules are essential for cell structure, the movement of nutrients, the duplication of DNA, and a variety of other activities. Since tumors depend on rapid cell division, it is important to disrupt these processes. Fenbendazole, a medication used to treat worms in dogs, can hinder the construction of microtubules in cells that are growing quickly. The way fenbendazole works is to reduce the speed of cancer cell division, which implies that cancer can be stopped from forming in the body.
Cancer therapies that focus on microtubules are not novel. Numerous renowned cancer treatments, such as vinca alkaloids (vinblastine, vinflunine, and so on), paclitaxel, and docetaxel, achieve this. Medications that bind to tubulin disrupt the activity of microtubules, which are essential for separating DNA and thus cell division, resulting in the death of cancer cells.
Researchers found that compared to other cancer treatments like nocodazole and colchicine, the fenbendazole dog dewormer had a weaker effect on cellular microtubules. This is beneficial as it helps to explain why fenbendazole is relatively safe and less dangerous than the other chemotherapeutic drugs.
It is interesting to note that, unlike paclitaxel and vinca alkaloids, fenbendazole (a dog dewormer) did not alter the p-glycoprotein expression in humans. Patients who are often given paclitaxel and vinca alkaloids may become resistant to these and other medications due to their effect on glycoprotein, but the human body does not develop immunity to fenbendazole.
It appears that cancer cells are unlikely to develop a tolerance to fenbendazole and other cancer treatments, which is good news. As many cancer therapies become less effective with time, taking fenbendazole tablets for humans has been shown to be promising for those suffering from cancer.Research has recently discovered that administering Fenbendazole to non-small cell lung carcinoma (NSCLC) cells leads to the death of up to 30% of them after 32 hours. Although this was observed in a laboratory setting, it may take a significantly longer period of time for humans to experience the initial effects of the canine dewormer when used to treat cancer. For more visit: Fenbendazole.org